556 related articles for article (PubMed ID: 31313064)
21. FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.
Takasugi N; Sasaki T; Ebinuma I; Osawa S; Isshiki H; Takeo K; Tomita T; Iwatsubo T
PLoS One; 2013; 8(5):e64050. PubMed ID: 23667698
[TBL] [Abstract][Full Text] [Related]
22. Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer's Disease.
Bascuñana P; Brackhan M; Möhle L; Wu J; Brüning T; Eiriz I; Jansone B; Pahnke J
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830699
[TBL] [Abstract][Full Text] [Related]
23. Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease.
Fagan SG; Bechet S; Dev KK
Mol Neurobiol; 2022 Mar; 59(3):1882-1895. PubMed ID: 35031916
[TBL] [Abstract][Full Text] [Related]
24. Lipid transporter Spns2 promotes microglia pro-inflammatory activation in response to amyloid-beta peptide.
Zhong L; Jiang X; Zhu Z; Qin H; Dinkins MB; Kong JN; Leanhart S; Wang R; Elsherbini A; Bieberich E; Zhao Y; Wang G
Glia; 2019 Mar; 67(3):498-511. PubMed ID: 30484906
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
Tsai HC; Han MH
Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
[TBL] [Abstract][Full Text] [Related]
27. Glial Sphingosine-Mediated Epigenetic Regulation Stabilizes Synaptic Function in
Yin P; Cai Y; Cui T; Berg AJ; Wang T; Morency DT; Paganelli PM; Lok C; Xue Y; Vicini S; Wang T
J Neurosci; 2023 Oct; 43(42):6954-6971. PubMed ID: 37669862
[TBL] [Abstract][Full Text] [Related]
28. Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.
Geffin R; Martinez R; de Las Pozas A; Issac B; McCarthy M
J Neurovirol; 2017 Dec; 23(6):808-824. PubMed ID: 28913617
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.
Lei M; Teo JD; Song H; McEwen HP; Yup Lee J; Couttas TA; Duncan T; Chesworth R; Bertz J; Przybyla M; Van Eersel J; Heng B; Guillemin GJ; Ittner LM; Fath T; Garner B; Ittner A; Karl T; Don AS
J Neurosci; 2019 Nov; 39(48):9645-9659. PubMed ID: 31641049
[TBL] [Abstract][Full Text] [Related]
30. Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons.
Doi Y; Takeuchi H; Horiuchi H; Hanyu T; Kawanokuchi J; Jin S; Parajuli B; Sonobe Y; Mizuno T; Suzumura A
PLoS One; 2013; 8(4):e61988. PubMed ID: 23593505
[TBL] [Abstract][Full Text] [Related]
31. Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase.
Motyl J; Przykaza Ł; Boguszewski PM; Kosson P; Strosznajder JB
Neuropharmacology; 2018 Jun; 135():139-150. PubMed ID: 29481916
[TBL] [Abstract][Full Text] [Related]
32. Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: comparison with memantine.
Hemmati F; Dargahi L; Nasoohi S; Omidbakhsh R; Mohamed Z; Chik Z; Naidu M; Ahmadiani A
Behav Brain Res; 2013 Sep; 252():415-21. PubMed ID: 23777795
[TBL] [Abstract][Full Text] [Related]
33. FTY720 attenuates excitotoxicity and neuroinflammation.
Cipriani R; Chara JC; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2015 May; 12():86. PubMed ID: 25953296
[TBL] [Abstract][Full Text] [Related]
34. Central effects of fingolimod.
Cruz VT; Fonseca J
Rev Neurol; 2014 Aug; 59(3):121-8. PubMed ID: 25030072
[TBL] [Abstract][Full Text] [Related]
35. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
[TBL] [Abstract][Full Text] [Related]
36. Total flavonoid extract from Dracoephalum moldavica L. attenuates β-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways.
Liu QS; Jiang HL; Wang Y; Wang LL; Zhang JX; He CH; Shao S; Zhang TT; Xing JG; Liu R
Life Sci; 2018 Jan; 193():214-225. PubMed ID: 29100755
[TBL] [Abstract][Full Text] [Related]
37. Prominence of central sphingosine-1-phosphate receptor-1 in attenuating aβ-induced injury by fingolimod.
Asle-Rousta M; Kolahdooz Z; Dargahi L; Ahmadiani A; Nasoohi S
J Mol Neurosci; 2014 Dec; 54(4):698-703. PubMed ID: 25239520
[TBL] [Abstract][Full Text] [Related]
38. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
[No Abstract] [Full Text] [Related]
39. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
